In patients with newly diagnosed extranodal natural killer/T-cell (NK/T) lymphoma, first-line programmed death-1 (PD-1) inhibitors combined with asparaginase-based chemotherapy were associated with ...
Combined-modality therapy (CMT) improves survival in patients with early-stage extranodal natural killer-/T-cell lymphoma (ENKTCL) compared with radiotherapy (RT) alone. However, the effect is ...
Zacks Small Cap Research on MSN
ESLA: Can Next-Generation CAR-T Therapy Improve Disease Control in Extranodal Lymphoma?
By David Bautz, PhD NASDAQ: ESLA READ THE FULL ESLA RESEARCH REPORT Business Update ARTEMIS Platform Potential in Treating Extramedullary Disease Extramedullary disease (EMD) remains one of the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results